Di Brizzi, Eugenia Veronica, Stefano Caccavale, Roberta Di Caprio, Francesco Cusano, Rocco De Pasquale, Valeria Falcomatà, Caterina Foti, et al. “Prospective Real-Life Multicenter Study of Tildrakizumab 200 Mg for Moderate-to-Severe Psoriasis: Who Is the Ideal Patient?”. Dermatology Practical & Conceptual 14, no. 4 (October 30, 2024): e2024284. Accessed March 16, 2025. https://www.dpcj.org/index.php/dpc/article/view/4769.